Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
PET Clinics
|
May 31, 2021
Theranostics in Neuroblastoma
Margarida Simao Rafael, Sarah Cohen-Gogo, Meredith S Irwin, et al.
Frontiers in Pediatrics
|
February 3, 2025
Case Report: Successful treatment of metastatic retinoblastoma with CNS involvement with anti-GD2 immunotherapy, intrathecal topotecan and reduced systemic chemotherapy
Cristina Larrosa, Margarida Simao-Rafael, Noelia Salvador, et al.
Paediatrics & Child Health
|
July 24, 2023
Precision oncology for children: A primer for paediatricians
Sarah Cohen-Gogo, Avram E Denburg, Anita Villani, et al.
Pediatric Blood & Cancer
|
August 19, 2021
Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome
Nida Usmani, Rebecca J Deyell, Carol Portwine, et al.
Cancers
|
May 11, 2024
Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy
Maite Gorostegui, Juan Pablo Muñoz, Sara Perez-Jaume, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
PET Clinics
|
May 31, 2021
Theranostics in Neuroblastoma
Margarida Simao Rafael, Sarah Cohen-Gogo, Meredith S Irwin, et al.
Frontiers in Pediatrics
|
February 3, 2025
Case Report: Successful treatment of metastatic retinoblastoma with CNS involvement with anti-GD2 immunotherapy, intrathecal topotecan and reduced systemic chemotherapy
Cristina Larrosa, Margarida Simao-Rafael, Noelia Salvador, et al.
Paediatrics & Child Health
|
July 24, 2023
Precision oncology for children: A primer for paediatricians
Sarah Cohen-Gogo, Avram E Denburg, Anita Villani, et al.
Pediatric Blood & Cancer
|
August 19, 2021
Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome
Nida Usmani, Rebecca J Deyell, Carol Portwine, et al.
Cancers
|
May 11, 2024
Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy
Maite Gorostegui, Juan Pablo Muñoz, Sara Perez-Jaume, et al.
Page
of 1